Research ArticleTechnology/Application
FDA 2011 Process Validation Guidance: Lifecycle Compliance Model
Cliff Campbell
PDA Journal of Pharmaceutical Science and Technology March 2014, 68 (2) 185-191; DOI: https://doi.org/10.5731/pdajpst.2014.00972
Cliff Campbell
Principal Consultant, Cliff Campbell Consulting Ltd., Blackrock, Cork, Ireland
B.E.
References
- 1.↵
FDA Guidance for Industry (Final). Process Validation: General Principles and Practices, January 2011; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070336.pdf.
- 2.↵
FDA Guidance for Industry and Review Staff (Draft). Target Product Profile: A Strategic Development Process Tool, March 2007; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM080593.pdf.
- 3.↵
FDA Guidance for Industry (Final). Q10 Pharmaceutical Quality System, April 2009; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073517.pdf.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 68, Issue 2
March/April 2014
FDA 2011 Process Validation Guidance: Lifecycle Compliance Model
Cliff Campbell
PDA Journal of Pharmaceutical Science and Technology Mar 2014, 68 (2) 185-191; DOI: 10.5731/pdajpst.2014.00972
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.